CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC Financials - Benzinga

CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC

CASBFOTCPK

Trade with Public

Trade with Public

$4.60

At close: Aug 28, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC Financials

CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Current Updates On COVID-19 Vaccines

Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never had a 100 percent efficacy when it comes to respiratory viruses, so anything between 50 and 100% will be the best we've got as the WHO believes everything above 50 percent efficacy is acceptable.

IAM Newswire